Abstract
Type I oculocutaneous albinism (OCA) is caused by the reduction in or absence of activity of tyrosinase in melanocytes in skin, hair, and the eyes, the result of mutations of the tyrosinase gene. To date, a total of 22 unique mutations in the coding region of tyrosinase have been described in the literature. In this report we present 5 additional mutations of the tyrosinase gene associated with type I-A OCA in four individuals, including 2 missense, 1 frameshift and 2 nonsense mutations, and review the relevant literature on all published mutations. Analysis of the distribution of all identified missense mutations (n = 17) shows that most cluster in three areas of the gene and involve amino acids conserved between humans and the mouse. Two clusters involve the copper A and copper B binding sites and may disrupt the metal ion-protein interaction necessary for enzyme function. The third cluster in exon I could represent a functional domain important in enzyme function such as the tyrosine or the dihydroxyphenylalanine (DOPA) binding site of the enzyme. Small deletions or insertions resulting in frameshift mutations and nonsense mutations are distributed throughout the coding region and do not appear to cluster.
References
Barton DE, Kwon BS, Francke U (1988) Human tyrosinase gene, mapped to chromosome 11 (q14→q21), defines second region of homology with mouse chromosome 7. Genomics 3:17–24
Chintamaneni CD, Halaban R, Kobayashi Y, Witkop CJ Jr, Kwon BS (1991) A single base insertion in the putative transmemrane domain of the tyrosinase gene as a cause for tyrosinasenegative oculocutaneous albinism. Proc Natl Acad Sci USA 88:5272–5276
Giebel LB, Strunk KM, King RA, Hanifin JM, Spritz RA (1990) A frequent tyrosinase gene mutation in classic tyrosinase-negative (type IA) oculocutaneous albinism. Proc Natl Acad Sci USA 87:3255–3258
Giebel LB, Strunk KM, Spritz RA (1991a) Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics 9:435–445
Giebel LB, Musarella MA, Spritz RA (1991b) A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinasenegative (type IA) oculocutaneous albinism. J Med Genet 28:464–467
Giebel LB, Tripathi RK, Strunk KM, Hanifin JM, Jackson CE, King RA, Spritz RA (1991c) Tyrosinase gene mutations associated with type IB (“yellow”) oculocutaneous albinism. Am J Hum Genet 48:1159–1167
Giebel LB, Tripathi RK, King RA, Spritz RA (1991d) A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. J Clin Invest 87:1119–1122
Hearing VJ, Jimenez M (1989) Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 2:75–85
Kidson SH, Fabian BC (1981) The effect of temperature on tyrosinase activity in Himalayan mouse skin. J Exp Zool 215:91–97
Kikuchi H, Hara S, Ishiguro S, Tamai M, Wantanabe M (1990) Detection of point mutation in the tyrosinase gene of a Japanese albino patient by a direct sequencing of amplified DNA. Hum Genet 85:123–124
King RA, Oetting WS (1992) Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism. In: Mishima Y (ed) The pigment cell: from the molecular to the clinical level. The XIV IPCC Proceedings, Kobe 1990. Munksgaard, Copenhagen
King RA, Summers CG (1988) Albinism. Dermatol Clin 6:217–228
King RA, Townsend D, Oetting W, Summers CG, Olds DP, White JG, Spritz RA (1991a) Temperature sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. J Clin Invest 87:1046–1053
King RA, Mentink MM, Oetting WS (1991b) Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase related) oculocutaneous albinism. Mol Biol Med 8:19–29
Kwon BS, Halaban R, Chintamaneni CD (1989) Molecular basis of mouse Himalayan mutation. Biochem Biophys Res Comm 161:252–260
Kunkel TA (1985) The mutational specificity of DNA polymeraseαand -γ during in vitro DNA synthesis. J Biol Chem 260:12866–12874
Lerner AB, Fitzpatrick TB (1950) Biochemistry of melanin formation. Physiol Rev 30:91–126
Litz CE, Taylor KA, Qiu JS, Pescovitz OH, Martinville B de (1988) Absence of detectable chromosomal and molecular abnormalities in monozygotic twins discordant for the Wiedemann-Beckwith Syndrome. Am J Med Genet 30:821–833
Nance WE, Jackson CE, Witkop CJ Jr (1970) Amish albinism: a distinctive autosomal recessive phenotype. Am J Hum Genet 22:579–586
Oetting WS, Handoko HY, Mentink MM, Paller AS, White JG, King RA (1991a) Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. J Invest Dermatol 97:15–19
Oetting WS, Mentink MM, Summers CG, Lewis RA, White JG, King RA (1991b) Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism. J Hum Genet 49:199–206
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA (1985) Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Shibahara S, Tomita Y, Tagami H, Muller RM, Cohen T (1988) Molecular basis for the heterogeneity of human tyrosinase. Tohoku J Exp Med 156:403–414
Spritz RA, Strunk K, Giebel LB, King RA (1990) Detection of tyrosinase gene mutations in a patient with type IA oculocutaneous albinism. N Engl J Med 322:1724–1728
Spritz RA, Strunk KM, Hsieh C-L, Sekhon S, Francke U (1991) Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism. Am J Hum Genet 48:318–324
Streisinger G, Owen J (1985) Mechanisms of spontaneous and induced frameshift mutation in bacteriophage T4. Genetics 109:633–659
Streisinger G, Okada Y, Emrich J, Newton J, Tsugita A, Terzaghi E, Inouye M (1966) Frameshift mutations and the genetic code. Cold Spring Harb Symp Quant Biol 31:77–84
Takeda A, Tomita Y, Matsunaga J, Tagami H, Shibahara S (1990) Molecular basis of tyrosinase-negative oculocutaneous albinism. J Biol Chem 265:17792–17797
Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S (1989) Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun 164:990–996
Witkop CJ Jr, Quevedo WC Jr, Fitzpatrick TB, King RA (1989) Albinism and the disorders of pigment metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 2905–2947
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oetting, W.S., King, R.A. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism. Hum Genet 90, 258–262 (1992). https://doi.org/10.1007/BF00220074
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00220074